Upregulation of the transient receptor potential ankyrin 1 ion channel in the inflamed human and mouse colon and its protective roles

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Kun, József ^a,b   Szitter, István ^a,b   Kemény, Ágnes ^a,b   Perkecz, Anikó ^a   Kereskai, László ^a   Pohóczky, Krisztina ^a   Vincze, Áron ^b   Gódi, Szilárd ^b   Szabó, Imre ^b   Szolcsányi, János ^a   Pintér, Erika ^a,b   Helyes, Zsuzsanna ^a,b  

^a UNIVERSITY OF PÉCS   (Hungary)

^b UNIVERSITY OF PÉCS   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

CXCL13 CHEMOKINE; CXCL9 CHEMOKINE; DEXTRAN SULFATE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; MESSENGER RNA; NEUROKININ 1 RECEPTOR; NEUROKININ A; NEUROKININ B; SUBSTANCE P; TRANSIENT RECEPTOR POTENTIAL CHANNEL A1; TUMOR NECROSIS FACTOR ALPHA; VANILLOID RECEPTOR 1; CALCIUM CHANNEL; NERVE PROTEIN; NEUROPEPTIDE; PRIMER DNA; TRANSIENT RECEPTOR POTENTIAL CHANNEL; TRPA1 PROTEIN, HUMAN; TRPA1 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLINICAL ARTICLE; COLITIS; COLON BIOPSY; COLON PROTECTION; CONTROLLED STUDY; CROHN DISEASE; DISEASE ACTIVITY; DISEASE MODEL; FECES ANALYSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREGULATION; INFLAMMATORY BOWEL DISEASE; INTESTINE EPITHELIUM; KNOCKOUT MOUSE; MACROPHAGE; MALE; MOUSE; NERVE CELL; NONHUMAN; POLYMERASE CHAIN REACTION; PROTECTION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; ULCERATIVE COLITIS; UPREGULATION; WEIGHT REDUCTION; WILD TYPE; ANIMAL; COLON; GENE EXPRESSION; GENETICS; METABOLISM; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; BASE SEQUENCE; CALCIUM CHANNELS; COLITIS; COLON; DNA PRIMERS; GENE EXPRESSION; HUMANS; MICE; MICE, KNOCKOUT; NERVE TISSUE PROTEINS; NEUROPEPTIDES; POLYMERASE CHAIN REACTION; TRANSIENT RECEPTOR POTENTIAL CHANNELS; UP-REGULATION;

EID: 84907494661     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0108164     Document Type: Article

References (103)

1. Rubin DC, Shaker A, Levin MS (2012) Chronic intestinal inflammation: inflammatory bowel disease and colitis-associated colon cancer. Front Immunol 3: 107.
2. Solomon L, Mansor S, Mallon P, Donnelly E, Hoper M, et al. (2010) The dextran sulphate sodium (DSS) model of colitis: an overview. Comp Clin Path 19: 235-239.
3. Perše M, Cerar A (2012) Dextran sodium sulphate colitis mouse model: traps and tricks. J Biomed Biotechnol 2012: 718617
4. McLean MH, Neurath MF, Durum SK (2014) Targeting Interleukins for the Treatment of Inflammatory Bowel Disease-What Lies Beyond Anti-TNF Therapy? Inflamm Bowel Dis 20: 389-397.
5. Szolcsányi J (1982) Capsaicin type pungent agents producing pyrexia. Pyretics and Antipyretics.
6. Szolcsányi J (2004) Forty years in capsaicin research for sensory pharmacology and physiology. Neuropeptides 38: 377-384.
7. Holzer P (2011) TRP channels in the digestive system. Curr Pharm Biotechnol 12: 24-34.
8. Holzer P (2011) Transient receptor potential (TRP) channels as drug targets for diseases of the digestive system. Pharmacol Ther 131: 142-170.
9. Holzer P (1992) Peptidergic sensory neurons in the control of vascular functions: mechanisms and significance in the cutaneous and splanchnic vascular beds. Rev Physiol Biochem Pharmacol 121: 49-146.
10. Szolcsanyi J, Jancso-Gabor A (1976) Sensory effects of capsaicin congeners. Part II: Importance of chemical structure and pungency in desensitizing activity of capsaicin-type compounds. Arzneimittelforschung 26: 33-37.
11. Szitter I, Pozsgai G, Sandor K, Elekes K, Kemeny A, et al. (2010) The role of transient receptor potential vanilloid 1 (TRPV1) receptors in dextran sulfateinduced colitis in mice. J Mol Neurosci 42: 80-88.
12. Lee J, Yamamoto T, Kuramoto H, Kadowaki M (2012) TRPV1 expressing extrinsic primary sensory neurons play a protective role in mouse oxazoloneinduced colitis. Auton Neurosci 166: 72-76.
13. Holzer P (2004) Vanilloid receptor TRPV1: hot on the tongue and inflaming the colon. Neurogastroenterol Motil 16: 697-699.
14. Fujino K, Takami Y, de la Fuente SG, Ludwig K a, Mantyh CR (2004) Inhibition of the vanilloid receptor subtype-1 attenuates TNBS-colitis. J Gastrointest Surg 8: 842-7; discussion 847-8.
15. Kimball ES, Wallace NH, Schneider CR, D'Andrea MR, Hornby PJ (2004) Vanilloid receptor 1 antagonists attenuate disease severity in dextran sulphate sodium-induced colitis in mice. Neurogastroenterol Motil 16: 811-818.
16. Massa F, Sibaev A, Marsicano G, Blaudzun H, Storr M, et al. (2006) Vanilloid receptor (TRPV1)-deficient mice show increased susceptibility to dinitrobenzene sulfonic acid induced colitis. J Mol Med (Berl) 84: 142-146.
17. Goso C, Evangelista S, Tramontana M, Manzini S, Blumberg PM, et al. (1993) Topical capsaicin administration protects against trinitrobenzene sulfonic acidinduced colitis in the rat. Eur J Pharmacol 249: 185-190.
18. Vinuesa AG, Sancho R, García-Limones C, Behrens A, ten Dijke P, et al. (2012) Vanilloid receptor-1 regulates neurogenic inflammation in colon and protects mice from colon cancer. Cancer Res 72: 1705-1716.
19. Nilius B, Appendino G, Owsianik G (2012) The transient receptor potential channel TRPA1: from gene to pathophysiology. Pflugers Arch 464: 425-458.
20. Story GM, Peier AM, Reeve AJ, Eid SR, Mosbacher J, et al. (2003) ANKTM1, a TRP-like channel expressed in nociceptive neurons, is activated by cold temperatures. Cell 112: 819-829.
21. Jordt S, Bautista DM, Chuang H, Meng ID, Julius D (2004) Mustard oils and cannabinoids excite sensory nerve fibres through the TRP channel ANKTM1. Nature 427: 260-264.
22. Nagata K, Duggan A, Kumar G, García-Añoveros J (2005) Nociceptor and hair cell transducer properties of TRPA1, a channel for pain and hearing. J Neurosci 25: 4052-4061.
23. Spahn V, Stein C, Zöllner C (2014) Modulation of transient receptor vanilloid 1 activity by transient receptor potential ankyrin Mol Pharmacol 85: 335-344.
24. Kobayashi K, Fukuoka T, Obata K, Yamanaka H, Dai Y, et al. (2005) Distinct expression of TRPM8, TRPA1, and TRPV1 mRNAs in rat primary afferent neurons with adelta/c-fibers and colocalization with trk receptors. J Comp Neurol 493: 596-606.
25. Storti B, Bizzarri R, Cardarelli F, Beltram F (2012) Intact microtubules preserve transient receptor potential vanilloid 1 (TRPV1) functionality through receptor binding. J Biol Chem 287: 7803-7811.
26. Steenland HW, Ko SW, Wu L-J, Zhuo M (2006) Hot receptors in the brain. Mol Pain 2:34
27. Han P, Korepanova A V, Vos MH, Moreland RB, Chiu ML, et al. (2013) Quantification of TRPV1 protein levels in rat tissues to understand its physiological roles. J Mol Neurosci 50: 23-32.
28. Nilius B, Szallasi A (2014) Transient receptor potential channels as drug targets: from the science of basic research to the art of medicine. Pharmacol Rev 66: 676-814.
29. Doihara H, Nozawa K, Kawabata-Shoda E, Kojima R, Yokoyama T, et al. (2009) Molecular cloning and characterization of dog TRPA1 and AITC stimulate the gastrointestinal motility through TRPA1 in conscious dogs. Eur J Pharmacol 617: 124-129.
30. De Moura JC, Noroes MM, Rachetti VDPS, Lobão-Soares B, Preti D, et al. (2014) The blockade of transient receptor potential ankirin 1 (TRPA1) signaling mediates antidepressant- and anxiolytic-like actions in mice. Br J Pharmacol 1: 1-26.
31. Fernandes ES, Fernandes M a, Keeble JE (2012) The functions of TRPA1 and TRPV1: moving away from sensory nerves. Br J Pharmacol 166: 510-521.
32. Bandell M, Story GM, Hwang SW, Viswanath V, Eid SR, et al. (2004) Noxious cold ion channel TRPA1 is activated by pungent compounds and bradykinin. Neuron 41: 849-857.
33. Taylor-Clark TE, McAlexander M a, Nassenstein C, Sheardown S a, Wilson S, et al. (2008) Relative contributions of TRPA1 and TRPV1 channels in the activation of vagal bronchopulmonary C-fibres by the endogenous autacoid 4- oxononenal. J Physiol 586: 3447-3459.
34. Takahashi N, Mizuno Y, Kozai D (2008) Molecular characterization of TRPA1 channel activation by cysteine-reactive inflammatory mediators. Channels 2: 1-12.
35. Takahashi N, Mori Y (2011) TRP Channels as Sensors and Signal Integrators of Redox Status Changes. Front Pharmacol 2:58
36. Trevisani M, Siemens J, Materazzi S, Bautista DM, Nassini R, et al. (2007) 4- Hydroxynonenal, an endogenous aldehyde, causes pain and neurogenic inflammation through activation of the irritant receptor TRPA1. PNAS 104: 13519-13524.
37. Brain SD, Williams TJ, Tippins JR, Morris HR, MacIntyre I (1985) Calcitonin gene-related peptide is a potent vasodilator. Nature 313: 54-56.
38. Szolcsányi J (1996) Capsaicin-sensitive sensory nerve terminals with local and systemic efferent functions : facts and scopes of an unorthodox neuroregulatory mechanisms. Prog Brain Res 113: 343-359.
39. Engel M a, Leffler A, Niedermirtl F, Babes A, Zimmermann K, et al. (2011) TRPA1 and substance P mediate colitis in mice. Gastroenterology 141: 1346- 1358.
40. Engel M a, Khalil M, Siklosi N, Mueller-Tribbensee SM, Neuhuber WL, et al. (2012) Opposite effects of substance P and calcitonin gene-related peptide in oxazolone colitis. Dig Liver Dis 44: 24-29
41. Kimball ES, Prouty SP, Pavlick KP, Wallace NH, Schneider CR, et al. (2007) Stimulation of neuronal receptors, neuropeptides and cytokines during experimental oil of mustard colitis. Neurogastroenterol Motil 19: 390-400.
42. Engel MA, Becker C, Reeh PW, Neurath MF (2011) Role of sensory neurons in colitis: increasing evidence for a neuroimmune link in the gut. Inflamm Bowel Dis 17: 1030-1033.
43. Bernstein C, Robert M, Eysselein E (1993) Rectal Substance P Concentrations Are Increased in Ulcerative Colitis But Not in Crohn 's Disease. Am J Gastroenterol 88: 908-913.
44. Szitter I, Pintér E, Perkecz A, Kemény A, Kun J, et al. (2014) Role of neurokinin 1 receptors in dextran sulfate-induced colitis: studies with genedeleted mice and the selective receptor antagonist netupitant. Inflamm Res.
45. Goode T (2000) Neurokinin-1 receptor expression in inflammatory bowel disease: molecular quantitation and localisation. Gut 47: 387-396.
46. Kaneko Y, Szallasi A (2013) Transient Receptor Potential (TRP) channels: a clinical perspective. Br J Pharmacol.
47. Romano B, Borrelli F, Fasolino I, Capasso R, Piscitelli F, et al. (2013) The cannabinoid TRPA1 agonist cannabichromene inhibits nitric oxide production in macrophages and ameliorates murine colitis. Br J Pharmacol 169: 213-229.
48. Pozsgai G, Helyes Z, Pinter E (2013) P42 Intricate regulatory role of hydrogen sufide in dextran sulfate sodium-induced colitis. Nitric Oxide 31: S53-S54.
49. Cattaruzza F, Spreadbury I, Miranda-Morales M, Grady EF, Vanner S, et al. (2010) Transient receptor potential ankyrin-1 has a major role in mediating visceral pain in mice. Am J Physiol Gastrointest Liver Physiol 298: G81-G91.
50. Szolcsányi J, Helyes Z, Oroszi G, Németh J, Pinter E (1998) Release of somatostatin and its role in the mediation of the anti-inflammatory effect induced by antidromic stimulation of sensory fibres of rat sciatic nerve. Br J Pharmacol 123: 936-942.
51. Szolcsanyi J, Pinter E, Helyes Z, Petho G (2011) Inhibition of the Function of TRPV1-Expressing Nociceptive Sensory Neurons by Somatostatin 4 Receptor Agonism: Mechanism and Therapeutical Implications. Curr Top Med Chem 11: 2253-2263.
52. Bautista DM, Jordt S-E, Nikai T, Tsuruda PR, Read AJ, et al. (2006) TRPA1 mediates the inflammatory actions of environmental irritants and proalgesic agents. Cell 124: 1269-1282.
53. Knowlton WM, Bifolck-Fisher A, Bautista DM, McKemy DD (2010) TRPM8, but not TRPA1, is required for neural and behavioral responses to acute noxious cold temperatures and cold-mimetics in vivo. Pain 150: 340-350.
54. Helyes Z, Elekes K, Sándor K, Szitter I, Kereskai L, et al. (2010) Involvement of preprotachykinin A gene-encoded peptides and the neurokinin 1 receptor in endotoxin-induced murine airway inflammation. Neuropeptides 44: 399-406.
55. Akbar a, Yiangou Y, Facer P, Walters JRF, Anand P, et al. (2008) Increased capsaicin receptor TRPV1-expressing sensory fibres in irritable bowel syndrome and their correlation with abdominal pain. Gut 57: 923-929
56. Kondo T, Oshima T, Obata K, Sakurai J, Knowles CH, et al. (2010) Role of transient receptor potential A1 in gastric nociception. Digestion 82: 150-155.
57. Yu Y-B, Yang J, Zuo X-L, Gao L-J, Wang P, et al. (2010) Transient receptor potential vanilloid-1 (TRPV1) and ankyrin-1 (TRPA1) participate in visceral hyperalgesia in chronic water avoidance stress rat model. Neurochem Res 35: 797-803.
58. Feng B, La JH, Schwartz ES, Gebhart GF (2012) Irritable bowel syndrome: methods, mechanisms, and pathophysiology. Neural and neuro-immune mechanisms of visceral hypersensitivity in irritable bowel syndrome. Am J - Physiol Gastrointest Liver Physiol 302: G1085-98.
59. Brederson J-D, Kym PR, Szallasi A (2013) Targeting TRP channels for pain relief. Eur J Pharmacol 716: 61-76.
60. Holzer P, Holzer-Petsche U (2001) Tachykinin receptors in the gut: physiological and pathological implications. Curr Opin Pharmacol 1: 583-590.
61. Menzies JR, McKee R, Corbett a D (2001) Differential alterations in tachykinin NK2 receptors in isolated colonic circular smooth muscle in inflammatory bowel disease and idiopathic chronic constipation. Regul Pept 99: 151-156.
62. Renzi D, Pellegrini B, Tonelli F, Surrenti C, Calabrò a (2000) Substance P (neurokinin-1) and neurokinin A (neurokinin-2) receptor gene and protein expression in the healthy and inflamed human intestine. Am J Pathol 157: 1511-1522.
63. Evangelista S, Tramontana M, Maggi C a (2008) Spatial and temporal expression of tachykinins and NK1- and NK2-receptor gene during TNB induced colitis in rats. Neuropeptides 42: 663-670.
64. Sanger GJ (2004) Neurokinin NK1 and NK3 receptors as targets for drugs to treat gastrointestinal motility disorders and pain. Br J Pharmacol 141: 1303-1312.
65. Vu JP, Million M, Larauche M, Luong L, Norris J, et al. (2014) Inhibition of Vasoactive Intestinal Polypeptide (VIP) Induces Resistance to Dextran Sodium Sulfate (DSS)-Induced Colitis in Mice. J Mol Neurosci 52: 37-47.
66. Todorovic V, Janic B, Koko V, Micev M, Ja N, et al. (1996) Colonic vasoactive intestinal polypeptide (VIP) in ulcerative colitis-a radioimmunoassay and immunohistochemical study. Hepatogastroenterology 43: 483-488.
67. Abad C, Juarranz Y, Martinez C, Arranz A, Rosignoli F, et al. (2005) cDNA array analysis of cytokines, chemokines, and receptors involved in the development of TNBS-induced colitis: homeostatic role of VIP. Inflamm Bowel Dis 11: 674-684.
68. Sigalet DL, Wallace LE, Holst JJ, Martin GR, Kaji T, et al. (2007) Enteric neural pathways mediate the anti-inflammatory actions of glucagon-like peptide J Mol Neurosci 293: 211-221.
69. Lakhan SE, Kirchgessner A (2010) Neuroinflammation in inflammatory bowel disease. J Neuroinflammation 7:37
70. Newman R, Cuan N, Hampartzoumian T, Connor SJ, Lloyd a R, et al. (2005) Vasoactive intestinal peptide impairs leucocyte migration but fails to modify experimental murine colitis. Clin Exp Immunol 139: 411-420.
71. Yadav M, Huang M-C, Goetzl EJ (2011) VPAC1 (vasoactive intestinal peptide (VIP) receptor type 1) G protein-coupled receptor mediation of VIP enhancement of murine experimental colitis. Cell Immunol 267: 124-132.
72. Vaudry D, Falluel-morel A, Bourgault S, Basille M, Burel D, et al. (2009) Pituitary Adenylate Cyclase-Activating Polypeptide and Its Receptors: 20 Years after the Discovery. Pharmacol Rev 61: 283-357.
73. Brynskov J, Foegh P, Pedersen G, Ellervik C, Kirkegaard T, et al. (2002) Tumour necrosis factor alpha converting enzyme (TACE) activity in the colonic mucosa of patients with inflammatory bowel disease. Gut 51: 37-43.
74. Deleporte A, Viennot S, Dupont B, Giletta C, Allaire M, et al. (2013) Efficacy of anti-TNF-alpha monoclonal antibodies in inflammatory bowel disease treatment. Int J Interf Cytokine Mediat Res 5: 11-31.
75. Bauer C, Loher F, Dauer M, Mayer C, Lehr HA, et al. (2007) The ICE inhibitor pralnacasan prevents DSS-induced colitis in C57BL/6 mice and suppresses IP-10 mRNA but not TNF-alpha mRNA expression. Dig Dis Sci 52: 1642-1652.
76. Alex P, Zachos NC, Nguyen T, Gonzales L, Chen T-E, et al. (2009) Distinct cytokine patterns identified from multiplex profiles of murine DSS and TNBSinduced colitis. Inflamm Bowel Dis 15: 341-352.
77. Tixier E, Galmiche J-P, Neunlist M (2006) Intestinal neuro-epithelial interactions modulate neuronal chemokines production. Biochem Biophys Res Commun 344: 554-561.
78. Li L, Liu Z, Yang X, Yan H, Bao S, et al. (2013) Bioluminescence imaging for IL-1b expression in experimental colitis. J Inflamm (Lond) 10:16
79. Carlsen HS, Baekkevold ES, Johansen F-E, Haraldsen G, Brandtzaeg P (2002) B cell attracting chemokine 1 (CXCL13) and its receptor CXCR5 are expressed in normal and aberrant gut associated lymphoid tissue. Gut 51: 364-371.
80. Poole DP, Pelayo JC, Cattaruzza F, Kuo Y-M, Gai G, et al. (2011) Transient receptor potential ankyrin 1 is expressed by inhibitory motoneurons of the mouse intestine. Gastroenterology 141: 565-75, 575.e1-4.
81. Izzo A, Capasso R, Aviello G, Borrelli F, Romano B, et al. (2012) Inhibitory effect of cannabichromene, a major non-psychotropic cannabinoid extracted from Cannabis sativa, on inflammation-induced hypermotility in mice. Br J Pharmacol 166: 1444-1460.
82. Yang J, Li Y, Zuo X, Zhen Y, Yu Y, et al. (2008) Transient receptor potential ankyrin-1 participates in visceral hyperalgesia following experimental colitis. Neurosci Lett 440: 237-241.
83. Schmidt M, Dubin AE, Petrus MJ, Earley TJ, Patapoutian A (2009) Nociceptive signals induce trafficking of TRPA1 to the plasma membrane. Neuron 64: 498-509.
84. Keszthelyi D, Troost FJ, Jonkers DM, Helyes Z, Hamer HM, et al. (2013) Alterations in mucosal neuropeptides in patients with irritable bowel syndrome and ulcerative colitis in remission: a role in pain symptom generation? Eur J Pain 17: 1299-1306.
85. Engel M a, Khalil M, Mueller-Tribbensee SM, Becker C, Neuhuber WL, et al. (2012) The proximodistal aggravation of colitis depends on substance P released from TRPV1-expressing sensory neurons. J Gastroenterol 47: 256-265.
86. Yiangou Y, Facer P, Dyer NHC, Chan CLH, Knowles C, et al. (2001) Vanilloid receptor 1 immunoreactivity in inflamed human bowel Variant Creutzfeldt-Jakob disease in an elderly patient. 357: 1338-1339.
87. Matsumoto K, Lo MW, Hosoya T, Tashima K, Takayama H, et al. (2012) Experimental colitis alters expression of 5-HT receptors and transient receptor potential vanilloid 1 leading to visceral hypersensitivity in mice. Lab Invest 92: 769-782.
88. Szallasi a, Nilsson S, Farkas-Szallasi T, Blumberg PM, Hökfelt T, et al. (1995) Vanilloid (capsaicin) receptors in the rat: distribution in the brain, regional differences in the spinal cord, axonal transport to the periphery, and depletion by systemic vanilloid treatment. Brain Res 703: 175-183
89. Tohda C, Sasaki M, Konemura T, Sasamura T, Itoh M, et al. (2001) Axonal transport of VR1 capsaicin receptor mRNA in primary afferents and its participation in inflammation-induced increase in capsaicin sensitivity. J Neurochem 76: 1628-1635.
90. Kun J, Helyes Z, Perkecz A, Bán Á. , Polgár B, et al. (2012) Effect of Surgical and Chemical Sensory Denervation on Non-neural Expression of the Transient Receptor Potential Vanilloid 1 (TRPV1) Receptors in the Rat. J Mol Neurosci 48: 795-803.
91. Szallasi A, Blumberg PM (1999) Vanilloid (Capsaicin) Receptors and Mechanisms. Pharmacol Rev 51: 159-211.
92. Pecze L, SzabóK, Széll M, Jósvay K, Kaszás K, et al. (2008) Human Keratinocytes Are Vanilloid Resistant. PLoS One 3: 1-10.
93. BarthóL, BenkóR, Patacchini R, Pethö G, Holzer-Petsche U, et al. (2004) Effects of capsaicin on visceral smooth muscle: a valuable tool for sensory neurotransmitter identification. Eur J Pharmacol 500: 143-157.
94. Matsumoto K, Kurosawa E, Terui H, Hosoya T, Tashima K, et al. (2009) Localization of TRPV1 and contractile effect of capsaicin in mouse large intestine: high abundance and sensitivity in rectum and distal colon. Am J Physiol Gastrointest Liver Physiol 297: G348-60.
95. Patapoutian A, Tate S, Woolf CJ (2010) Transient receptor potential channels : targeting pain at the source. 8: 55-68.
96. Chan CLH, Facer P, Davis JB, Smith GD, Egerton J, et al. (2003) Sensory fibres expressing capsaicin receptor TRPV1 in patients with rectal hypersensitivity and faecal urgency. Lancet 361: 385-391.
97. Holzer P (2003) Acid-sensitive ion channels in gastrointestinal function. Curr Opin Pharmacol 3: 618-625.
98. Anavi-goffer S, Mckay NG, Ashford MLJ, Coutts AA (2002) Vanilloid receptor type 1-immunoreactivity is expressed by intrinsic afferent neurones in the guinea-pig myenteric plexus. Neurosci Lett 319: 53-57.
99. Holzer P (2004) TRPV1 and the gut : from a tasty receptor for a painful vanilloid to a key player in hyperalgesia. Eur J Pharmacol 500: 231-241.
100. Steinbach EC, Plevy SE (2014) The role of macrophages and dendritic cells in the initiation of inflammation in IBD. Inflamm Bowel Dis 20: 166-175.
101. Nozawa K, Kawabata-Shoda E, Doihara H, Kojima R, Okada H, et al. (2009) TRPA1 regulates gastrointestinal motility through serotonin release from enterochromaffin cells. Proc Natl Acad Sci U S A 106: 3408-3413.
102. Ahern GP (2011) 5-HT and the immune system. Curr Opin Pharmacol 11: 29-33
103. Chojnacki C, Wis̈niewska-Jarosińska M, Kulig G, Majsterek I, Reiter RJ, et al. (2013) Evaluation of enterochromaffin cells and melatonin secretion exponents in ulcerative colitis. World J Gastroenterol 19: 3602-3607.